Temasek Holdings (Private) LTD Ab Cellera Biologics Inc. Transaction History

Temasek Holdings (Private) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 15, 2023	BUY	$5.72 - $10.65 $1.61 Million - $3 Million	281,729 New	281,729 $3 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $1.61 Million - $3 Million	281,729 New	281,729 $3 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $3.21 Million - $4.38 Million	-246,907 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $150,118 - $215,726	10,109 Added 4.27%	246,907 $4.95 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $4.78 Million - $8.09 Million	236,798 New	236,798 $5.21 Million

155

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $807M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

Stay updated on Temasek Holdings (Private) LTD with notifications on news.